Has Mastaneh Nikravesh, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,604 in general payments to Mastaneh Nikravesh, MD across 38 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mastaneh Nikravesh, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mastaneh Nikravesh, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mastaneh Nikravesh, MD

Pain Medicine · la Mesa, CANPI 1508429143

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $3,106 of the $4,604 with a category attached, or 67.5%. 7 manufacturers reported payments, led by Medtronic at 58.1% of the total. Reporting peaked in 2024 at $3,274 and has fallen 92.3% since, to $252 in 2025.

$4,604in general payments, 2019–2025

Across 38 payments — averaging $121.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$3K
Abbott$1K
Si-bone, Inc.$396
GSK$153
Saluda Medical Americas, Inc.$117
Curonix LLC$72
plus $69 from 1 others

What the payments were for

Travel & lodging$3,10667%
Food & beverage$1,49833%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	23	$2,674
Abbott	4	$1,123
Si-bone, Inc.	3	$396
GSK	3	$153
Saluda Medical Americas, Inc.	1	$117
Curonix LLC	2	$72
Boston Scientific	2	$69

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,604 in reported general payments places this provider in the 65th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Medicare billing

Part B allowed, 2024

$1,935

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Lidocaine	13	$1,050
Duloxetine Hcl	12	$222
Pregabalin	17	$161
Gabapentin	11	$112

Paid to pharmacies, not to this prescriber.

Other pain medicine in la Mesa

Jason PopeSanta Rosa$2.1M
Ramana NaiduLarkspur$1.4M
Foead GeulaStudio City$1.3M
Krishnan ChakravarthyTemecula$1.3M
Kasra AmirdelfanWalnut Creek$783K
Eric GrigsbyNapa$499K
Jacqueline WeisbeinNapa$494K
Gerald SacksSanta Monica$389K
Samir ShethRoseville$356K
Einar OttestadStanford$352K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →